The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Reductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides
Abstract
For millennia, ginseng and some of its components have been used to treat a wide variety of medical conditions, including age-related memory impairment. Because of its purported effects and apparently low rate of side effects, ginseng remains one of the top selling natural product remedies in the United States. Given its potential role for improving age-related memory impairments and its common use in China for the treatment of Alzheimer's disease-like symptoms, we analyzed the effects of commercially available preparations of ginseng on the accumulation of the Alzheimer's amyloid beta peptide (Abeta) in a cell-based model system. In this model system, ginseng treatment resulted in a significant reduction in the levels of Abeta in the conditioned medium. We next examined the effects of several compounds isolated from ginseng and found that certain ginsenosides lowered Abeta concentration in a dose-dependent manner with ginsenoside Rg3 having an approximate IC50 of under 25 microM against Abeta42. Furthermore, we found that three of these isolated components, ginsenoside Rg1, Rg3, and RE, resulted in significant reductions in the amount of Abeta detected in the brains of animals after single oral doses of these agents. The results indicate that ginseng itself, or purified ginsenosides, may have similarly useful effects in human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“Without a treatment that significantly delays the progression of the disease, almost 14 million Americans are likely to be affected with AD by the middle of the 21 century, presenting an enormous economic and social burden (1).”
BackgroundKaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002) · JAMA · doi:10.1001/jama.287.3.337 · Cited by 1,845
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Search for natural products related to regeneration of the neuronal network
Tohda, C., Kuboyama, T., & Komatsu, K. (2005) · Neurosignals · doi:10.1159/000085384 · Cited by 257
Haugabook, S. J., Yager, D. M., Eckman, E. A., Golde, T. E., Younkin, S. G., & Eckman, C. B. (2001) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00388-0 · Cited by 39 · cited 4×
“A Chinese hamster ovary (CHO) cell line stably transfected with human APP 695wt, CHO 2B7 ( 25 ,26), was cultured in Ham’s F-12 medium (Life Technologies, Inc.) with 10% newborn calf serum, penicillin/streptomycin and maintained in 100 g/mg Zeocin (Invitrogen).”
MethodInfluentialSelf-citation
Cited by
Ginseng Compounds: An Update on their Molecular Mechanisms and Medical Applications
Lu, J.-M., Yao, Q., & Chen, C. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109788340767 · Cited by 606
Pharmacological potential of ginseng and its major component ginsenosides
Ratan, Z. A., Haidere, M. F., Hong, Y. H., Park, S. H., Lee, J.-O., Lee, J., & Cho, J. Y. (2021) · Journal of Ginseng Research · doi:10.1016/j.jgr.2020.02.004 · Cited by 543
The role of amyloid β peptide 42 in Alzheimer's disease
Findeis, M. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.006 · Cited by 324
Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
Seo, E.-J., Fischer, N., & Efferth, T. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.030 · Cited by 265
Learning by Failing: Ideas and Concepts to Tackle γ-Secretases in Alzheimer's Disease and Beyond
De Strooper, B., & Chávez Gutiérrez, L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124309 · Cited by 119
Metadata
- Authors
- Chen, F., Eckman, E. A., Eckman, C. B., Chen, F., Eckman, E. A., & Eckman, C. B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2006-04-24
- Volume
- 20
- Issue
- 8
- Pages
- 1269-1271
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2169988572
- Cited by
- 160
- References
- 5
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides. https://app.cochat.ai/papers/10.1096/fj.05-5530fje
- The paper
- Chen, F., Eckman, E. A., Eckman, C. B., Chen, F., Eckman, E. A., & Eckman, C. B. (2006). Reductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides. The FASEB Journal. https://doi.org/10.1096/fj.05-5530fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.